|Abbott Laboratories -- USA Stock|| |
USD 55.77 0.55 0.98%
Senior Vice President - Abbott Vascular
Mr. Deepak S. Nath is Senior Vice President Abbott Vascular of the Company. Currently he is Vice President, Vascular, Commercial. Between 2014 to 2015 he is Vice President, Molecular Diagnostics. Between 2012 to 2014 he is Divisional Vice President and General Manager, Ibis. Between 2011 to 2012 he is Divisional Vice President, CEEMEA, Vascular. Between 2009 to 2011 he is Divisional Vice President and General Manager, Nordics and Eastern European Operations, Vascular.
Age: 43 President Since 2015
224 667-6100 www.abbott.com
The company has Return on Asset of 3.45 %
which means that on every $100 spent on asset it made $3.45 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE)
of 4.05 %
implying that it generated $4.05 on every 100 dollars invested.
The company has 24.09 B in debt with debt to equity (D/E) ratio of 75.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. Abbott Laboratories has Current Ratio of 2.88 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
Abbott Laboratories manufactures and sells health care solutions worldwide. Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA. It is located in ILLINOIS, U.S.A and employs 74,000 people. Abbott Laboratories is listed under Pharmaceutical Products category by Fama And French industry classification.